Becton Dickinson and Company (BDX) 175.73 $BDX
The Cooper Companies (COO) Scales a New 52-Week High
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:09AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $182.21 on Jul 8, eventually closing a tad bit lower at $181.83.
HYH: 34.70 (+0.06), BDX: 175.73 (+0.03), BCR: 234.69 (-0.88), COO: 179.40 (+0.86)
Becton, Dickinson (BDX) at 52-Week High on New Launches
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:59AM CDT
Shares of Becton, Dickinson and Company (BDX) scaled a new 52-week high of $173.24 on Jul 7.
HYH: 34.70 (+0.06), DSCI: 4.14 (+0.01), ABMD: 117.59 (-0.17), BDX: 175.73 (+0.03)
Becton Dickinson Up 20.2% Since SmarTrend Uptrend Call (BDX)
Comtex SmarTrend(R) - Thu Jul 07, 1:25AM CDT
SmarTrend identified an Uptrend for Becton Dickinson (NYSE:BDX) on February 17th, 2016 at $143.14. In approximately 5 months, Becton Dickinson has returned 20.22% as of today's recent price of $172.07.
BDX: 175.73 (+0.03)
Becton Dickinson Rises 1.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jun 21, 12:50PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $168.55 to a high of $170.68. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $169.12 on volume of 708,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 175.73 (+0.03)
Becton Dickinson Falls 1.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jun 15, 12:45PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $166.55 to a high of $169.40. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $167.22 on volume of 347,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 175.73 (+0.03)
Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:07AM CDT
Becton, Dickinson and Company (BDX) recently announced a partnership with Central Admixture Pharmacy Services (CAPS).
HYH: 34.70 (+0.06), BDX: 175.73 (+0.03), BCR: 234.69 (-0.88), MDT: 88.89 (-0.03)
CAPS(R) and BD Form Collaboration to Provide Ready-to-Use, Pre-Filled Anesthesia Syringes for Use With the BD Intelliport(TM) Medication Management System
Marketwire Canada - Fri Jun 10, 4:31PM CDT
IRVINE, CA--(Marketwired - Jun 10, 2016) - Central Admixture Pharmacy Services, Inc. (CAPS) and BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that they have entered into a collaboration agreement that will offer BD Intelliport™ Medication Management System customers the opportunity to purchase a portfolio of frequently used CAPS' pre-filled anesthesia syringes capable of being automatically identified and utilized by the BD Intelliport System for real-time patient safety checks and hands-free electronic medication documentation.
BDX: 175.73 (+0.03)
Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 175.73 (+0.03), ELGX: 13.86 (+0.01), WAT: 147.72 (+0.11), OSUR: 6.51 (-0.08)
BD to Present at Investor Healthcare Conferences
PR Newswire - Fri Jun 03, 7:30AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in June 2016:
BDX: 175.73 (+0.03)
BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody(TM) System
PR Newswire - Thu May 26, 5:59AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the introduction of its newest cell sorter, the BD FACSMelody(TM) system. Built for benchtop use, the new BD FACSMelody sorter is easy to learn, install and use and provides excellent sensitivity, resolution and sort purity. The simplicity of the BD FACSMelody follows in the footsteps of other newly launched BD flow cytometers such as the BD Accuri(TM) C6 Plus and BD FACSCelesta(TM) systems.
BDX: 175.73 (+0.03)
BD Board Declares Dividend
PR Newswire - Tue May 24, 3:15PM CDT
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on June 30, 2016 to holders of record on June 9, 2016. The indicated annual dividend rate is $2.64 per share.
BDX: 175.73 (+0.03)
Look for Shares of Becton Dickinson to Potentially Rebound after Yesterday's 1.52% Sell Off
Comtex SmarTrend(R) - Tue May 17, 3:41PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $165.78 to a high of $168.55. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $165.82 on volume of 376,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 175.73 (+0.03)
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 175.73 (+0.03), BCR: 234.62 (-0.95), MDT: 88.89 (-0.03), CNMD: 49.42 (-0.18)
BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX(TM) Vaginal Panel
PR Newswire - Fri May 13, 5:59AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained CE mark for the BD MAX(TM) Vaginal Panel. The new in vitro diagnostic (IVD) assay will provide laboratories and clinicians the ability to use a single test to detect microorganisms responsible for Bacterial Vaginosis (BV), Candidiasis (CA) and Trichomoniasis (TV), which are the most common infectious causes of vaginitis1.
BDX: 175.73 (+0.03)
Becton, Dickinson Becomes #214 Most Shorted S&P 500 Component, Replacing Salesforce.com
MarketNewsVideo.com - Thu May 12, 12:49PM CDT
The most recent short interest data has been released for the 04/29/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a...
BDX: 175.73 (+0.03)
Becton Dickinson Set to Possibly Pullback After Yesterday's Rally of 2.05%
Comtex SmarTrend(R) - Thu May 05, 12:35PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $160.93 to a high of $164.98. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $162.25 on volume of 785,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 175.73 (+0.03)
Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 175.73 (+0.03), BCR: 234.62 (-0.95), ALGN: 84.40 (+0.03), CNMD: 49.42 (-0.18)
The Cooper Companies (COO) Scales a New 52-Week High
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:09AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $182.21 on Jul 8, eventually closing a tad bit lower at $181.83.
HYH: 34.70 (+0.06), BDX: 175.73 (+0.03), BCR: 234.69 (-0.88), COO: 179.40 (+0.86)
Becton, Dickinson (BDX) at 52-Week High on New Launches
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:59AM CDT
Shares of Becton, Dickinson and Company (BDX) scaled a new 52-week high of $173.24 on Jul 7.
HYH: 34.70 (+0.06), DSCI: 4.14 (+0.01), ABMD: 117.59 (-0.17), BDX: 175.73 (+0.03)
Becton Dickinson Up 20.2% Since SmarTrend Uptrend Call (BDX)
Comtex SmarTrend(R) - Thu Jul 07, 1:25AM CDT
SmarTrend identified an Uptrend for Becton Dickinson (NYSE:BDX) on February 17th, 2016 at $143.14. In approximately 5 months, Becton Dickinson has returned 20.22% as of today's recent price of $172.07.
BDX: 175.73 (+0.03)
Becton Dickinson Rises 1.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jun 21, 12:50PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $168.55 to a high of $170.68. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $169.12 on volume of 708,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 175.73 (+0.03)
Becton Dickinson Falls 1.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jun 15, 12:45PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $166.55 to a high of $169.40. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $167.22 on volume of 347,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 175.73 (+0.03)
Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:07AM CDT
Becton, Dickinson and Company (BDX) recently announced a partnership with Central Admixture Pharmacy Services (CAPS).
HYH: 34.70 (+0.06), BDX: 175.73 (+0.03), BCR: 234.69 (-0.88), MDT: 88.89 (-0.03)
CAPS(R) and BD Form Collaboration to Provide Ready-to-Use, Pre-Filled Anesthesia Syringes for Use With the BD Intelliport(TM) Medication Management System
Marketwire Canada - Fri Jun 10, 4:31PM CDT
IRVINE, CA--(Marketwired - Jun 10, 2016) - Central Admixture Pharmacy Services, Inc. (CAPS) and BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that they have entered into a collaboration agreement that will offer BD Intelliport™ Medication Management System customers the opportunity to purchase a portfolio of frequently used CAPS' pre-filled anesthesia syringes capable of being automatically identified and utilized by the BD Intelliport System for real-time patient safety checks and hands-free electronic medication documentation.
BDX: 175.73 (+0.03)
Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 175.73 (+0.03), ELGX: 13.86 (+0.01), WAT: 147.72 (+0.11), OSUR: 6.51 (-0.08)
BD to Present at Investor Healthcare Conferences
PR Newswire - Fri Jun 03, 7:30AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in June 2016:
BDX: 175.73 (+0.03)
BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody(TM) System
PR Newswire - Thu May 26, 5:59AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the introduction of its newest cell sorter, the BD FACSMelody(TM) system. Built for benchtop use, the new BD FACSMelody sorter is easy to learn, install and use and provides excellent sensitivity, resolution and sort purity. The simplicity of the BD FACSMelody follows in the footsteps of other newly launched BD flow cytometers such as the BD Accuri(TM) C6 Plus and BD FACSCelesta(TM) systems.
BDX: 175.73 (+0.03)
BD Board Declares Dividend
PR Newswire - Tue May 24, 3:15PM CDT
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on June 30, 2016 to holders of record on June 9, 2016. The indicated annual dividend rate is $2.64 per share.
BDX: 175.73 (+0.03)
Look for Shares of Becton Dickinson to Potentially Rebound after Yesterday's 1.52% Sell Off
Comtex SmarTrend(R) - Tue May 17, 3:41PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $165.78 to a high of $168.55. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $165.82 on volume of 376,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 175.73 (+0.03)
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 175.73 (+0.03), BCR: 234.62 (-0.95), MDT: 88.89 (-0.03), CNMD: 49.42 (-0.18)
BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX(TM) Vaginal Panel
PR Newswire - Fri May 13, 5:59AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained CE mark for the BD MAX(TM) Vaginal Panel. The new in vitro diagnostic (IVD) assay will provide laboratories and clinicians the ability to use a single test to detect microorganisms responsible for Bacterial Vaginosis (BV), Candidiasis (CA) and Trichomoniasis (TV), which are the most common infectious causes of vaginitis1.
BDX: 175.73 (+0.03)
Becton, Dickinson Becomes #214 Most Shorted S&P 500 Component, Replacing Salesforce.com
MarketNewsVideo.com - Thu May 12, 12:49PM CDT
The most recent short interest data has been released for the 04/29/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a...
BDX: 175.73 (+0.03)
Becton Dickinson Set to Possibly Pullback After Yesterday's Rally of 2.05%
Comtex SmarTrend(R) - Thu May 05, 12:35PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $160.93 to a high of $164.98. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $162.25 on volume of 785,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 175.73 (+0.03)
Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 175.73 (+0.03), BCR: 234.62 (-0.95), ALGN: 84.40 (+0.03), CNMD: 49.42 (-0.18)
